findmyKOL

Matthew Brams, MD

Enriched profile

Chief Medical Officer & Co-Founder, Cingulate Inc. · Cingulate Inc.

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Houston, TX · South Central · United StatesSpecialtyPsychiatryFocusPsychiatry
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Matthew Brams is Chief Medical Officer & Co-Founder, Cingulate Inc. at Cingulate Inc.. ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 16 Oct 2026

Matthew Brams, MD, is Chief Medical Officer & Co-Founder, Cingulate Inc.. The public record shows 49 publications with 1,318 citations (h-index 22), centered on Psychiatry. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 28 companies.

  • Top research focus: Psychiatry
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 28 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Attention Deficit Disorder with Hyperactivity1 trial

Research focus

OpenAlex concept fingerprint
Psychiatry

Drugs & molecules

across trials, industry payments and publications
AripiprazoleClinical trials—Industry payments418Publications—Rexultigeneric · BrexpiprazoleClinical trials—Industry payments274Publications—Austedogeneric · DeutetrabenazineClinical trials—Industry payments138Publications—Fanaptgeneric · IloperidoneClinical trials—Industry payments100Publications—Caplytageneric · LumateperoneClinical trials—Industry payments48Publications—Quillivantgeneric · MethylphenidateClinical trials—Industry payments30Publications—Cobenfygeneric · Trospium / xanomelineClinical trials—Industry payments29Publications—Uzedygeneric · RisperidoneClinical trials—Industry payments29Publications—Vraylargeneric · CariprazineClinical trials—Industry payments21Publications—Xelstrymgeneric · DextroamphetamineClinical trials—Industry payments16Publications—Azstarysgeneric · Dexmethylphenidate / serdexmethylphenidateClinical trials—Industry payments14Publications—Trintellixgeneric · VortioxetineClinical trials—Industry payments12Publications—

Works with

trial sponsors and companies reporting payments
Otsuka America Pharmaceutical, Inc.Clinical trials—Industry payments559Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments166Vanda Pharmaceuticals Inc.Clinical trials—Industry payments100ITI, Inc.Clinical trials—Industry payments48E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments43Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments32Tris Pharma IncClinical trials—Industry payments25Abbvie Inc.Clinical trials—Industry payments21Corium, LLCClinical trials—Industry payments15Takeda Pharmaceuticals U.S.A., Inc.Clinical trials—Industry payments13Bausch Health US, LLCClinical trials—Industry payments8Lundbeck LLCClinical trials—Industry payments8Janssen Pharmaceuticals, IncClinical trials—Industry payments6Neurocrine Biosciences, Inc.Clinical trials—Industry payments6Jazz Pharmaceuticals Inc.Clinical trials—Industry payments5Merck Sharp & Dohme LLCClinical trials—Industry payments5Sunovion Pharmaceuticals Inc.Clinical trials—Industry payments5Indivior Inc.Clinical trials—Industry payments4LivaNova USA, Inc.Clinical trials—Industry payments4Merck Sharp & Dohme CorporationClinical trials—Industry payments4Axsome Therapeutics, Inc.Clinical trials—Industry payments3Alkermes, Inc.Clinical trials—Industry payments2Almatica Pharma LLCClinical trials—Industry payments2Supernus Pharmaceuticals, Inc.Clinical trials—Industry payments2Collegium Pharmaceutical, Inc.Clinical trials—Industry payments1Ironshore Pharmaceuticals Inc.Clinical trials—Industry payments1NovartisClinical trials1Industry payments—Noven Therapeutics, LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
28companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

28 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    93.9%
    Benzodiazepine23.2%
    Alprazolam49%Clonazepam20%Lorazepam15%Temazepam8%Diazepam8%
    Part D<11 patients
    Atypical Antipsychotic16.3%
    Quetiapine Fumarate27%Olanzapine16%Risperidone13%Ziprasidone Hcl9%Rexulti8%Aripiprazole6%Quetiapine Fumarate Er6%Lurasidone Hcl4%Vraylar3%Abilify Maintena3%Clozapine3%Latuda3%
    Part D<11 patients

    + 19 more classes in this area

  • Cardiovascular

    4.5%
    Statin2%
    Atorvastatin Calcium100%
    Part D≥38 patients
    Central alpha-2 Adrenergic Agonist0.9%
    Clonidine Hcl100%
    Part D<11 patients

    + 3 more classes in this area

  • Hormonal (systemic)

    1.2%
    l-Thyroxine1.2%
    Levothyroxine Sodium100%
    Part D≥17 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)94.1% facility · 5.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/matthew-brams-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Matthew-Brams-39892503

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • LinkedIn

    linkedin.com/in/matthew-brams-89367514

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • Other

    cingulate.com/news-releases/news-release-details/cingulate-therapeutics-appoints-experienced-lead-investigator

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cingulate.com ↗
  • Other

    hcplive.com/view/importance-adhd-research-conference-brams

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
  • Other

    psychiatrist.com/author/matthew-brams

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psychiatrist.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    University of Texas Health Science Center at Houston (McGovern Medical School)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →memorialparkpsychiatry.com ↗
  • B.A./undergraduate degree

    University of Texas at Austin

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →memorialparkpsychiatry.com ↗
  • Residency

    Adult, Adolescent, and Child Psychiatry, Baylor College of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →memorialparkpsychiatry.com ↗
  • Board Certified

    Adult Psychiatry, American Board of Psychiatry and Neurology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oakbendmedcenter.org ↗
  • Board Certified

    Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oakbendmedcenter.org ↗

Editorial & leadership roles

journal and society appointments
  • Principal Investigator

    Cingulate Therapeutics clinical trials

    2012
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗
  • Clinical Associate Professor

    Menninger Department of Psychiatry, Baylor College of Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cingulate.com ↗
  • Medical Director & Principal

    Bayou City Research, Inc.

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cingulate.com ↗
  • Director

    Depelchin Children's Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →memorialparkpsychiatry.com ↗
  • Senior National Board Examiner

    American Board of Psychiatry and Neurology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oakbendmedcenter.org ↗
  • Member

    American Academy of Child and Adolescent Psychiatry

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →memorialparkpsychiatry.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.